Stephen Engelberg
Stephen Engelberg is ProPublica’s editor-in-chief and served as founding managing editor from 2008–2012.
Need to Get in Touch?
Stephen Engelberg was the founding managing editor of ProPublica from 2008–2012, and became editor-in-chief on January 1, 2013. He came to ProPublica from The Oregonian in Portland, where he had been a managing editor since 2002. Before joining The Oregonian, Mr. Engelberg worked for The New York Times for 18 years, including stints in Washington, D.C., and Warsaw, Poland, as well as in New York. He is a member of the Pulitzer Prize Board.
Mr. Engelberg’s work since 1996 has focused largely on the editing of investigative projects. He started the Times’s investigative unit in 2000. Projects he supervised at the Times on Mexican corruption (published in 1997) and the rise of Al Qaeda (published beginning in January 2001) were awarded the Pulitzer Prize. During his years at The Oregonian, the paper won the Pulitzer for breaking news and was a finalist for its investigative work on methamphetamines and charities intended to help the disabled. He is the co-author of “Germs: Biological Weapons and America’s Secret War” (2001).
Mexico's Regional Newspapers Limit Reporting of Cartels' Role in Drug Violence
Mexico’s regional newspapers, the source of news for many in the country, downplay the role of drug cartels in assassinations and other attacks on civil authorities. Many papers don’t even cover all the drug-linked executions in their localities.
Experts, Intelligence Agencies Question a Defector's Claims About Burma's Nuclear Ambitions
An analysis that contends Burma has begun a program to build nuclear weapons is disputed by the Central Intelligence Agency, Department of Energy and outside experts who say the evidence provided by a Burmese defector does not support its conclusions.
Editor's Note: How We Got the Government's Secret Dialysis Data
After two years of delays, the government recently fulfilled ProPublica's request for data that track whether death, hospitalization and infection rates at dialysis clinics are better or worse than expected.
by Paul Steiger and Stephen Engelberg,
Editor's Note: Dollars for Docs
The stories ProPublica is publishing today on the drug industry are part of a broader effort to expand the possibilities of collaborative journalism.
How WikiLeaks Could Change the Way Reporters Deal With Secrets
Journalists often consulted with sources on whether to release sensitive information, but the WkiLeaks case changes all that.
Slate Takes a Closer Look at the Tragedy of a Bullied Teenager
A Slate report delves into the case of Phoebe Prince and the teenagers accused of driving her to suicide.
Reverse Ferret! When Stories Bite Back
While politicians jumped the gun in the Shirley Sherrod saga, reporters once again showed the value of … reporting.